5 արդյունքներ
SUMMARY OF THE INVENTION
The present invention relates to novel compounds of formula I ##STR2##
in which W is O, S, S(O) or S(O).sub.2 ; X is --SR4, --S(O)R4, --S(O).sub.2 R4, or --S(O).sub.2 NR5R6; or X is --C(O)NR5R6 provided that --C(O)NR5R6 is located at the 3'-, 4'- or 5'-position; Y is O or
SUMMARY OF THE INVENTION
The present invention relates to novel compounds of formula I ##STR2##
in which W is O, S, S(O) or S(O).sub.2 ; X is --SR4, --S(O)R4, --S(O).sub.2 R4, or --S(O).sub.2 NR5R6; or X is --C(O)NR5R6 provided that --C(O)NR5R6 is located at the 3'-, 4'- or 5'-position; Y is O or
BACKGROUND OF THE INVENTION
Foams and, in particular, foam emulsions are complex dispersion systems which do not form under all circumstances. Slight shifts in foam emulsion composition, such as by the addition of active ingredients, may destabilize the foam.
Hyperhidrosis is a medical condition
FIELD OF THE INVENTION
The present invention relates to sulfonamide derivatives, to the process for preparing them and to their therapeutic use.
BACKGROUND OF THE INVENTION
Orexins A and B (or hypocretins 1 and 2) are hypothalamus neuropeptides of 33 and 28 amino acids, respectively, recently
STATEMENT REGARDING SEQUENCE LISTING
The Sequence Listing associated with this application is provided in text format in lieu of a paper copy, and is hereby incorporated by reference into the specification. The name of the text file containing the Sequence Listing is